Despite ongoing structural headwinds, a demanding valuation relative to peers, muted global nicotine growth prospects, and continued analyst preference for British American, the consensus analyst price target for Altria Group has been revised upward from $58.54 to $61.62.
Analyst Commentary
- Structural headwinds impacting Altria's business outlook.
- Perceived demanding valuation relative to peers.
- Low-single-digit global nicotine category growth projected from combustibles and next-generation products.
- Stronger preference for British American as a top pick in the sector.
- Broader positive outlook on tobacco staples does not translate to bullishness on Altria specifically.
What's in the News
- Altria completed repurchase of 10,396,450 shares (0.62% of shares outstanding) for $599.95 million under its buyback program announced January 30, 2025.
- Shareholder approval was obtained to retain PricewaterhouseCoopers LLP as Altria's independent registered public accounting firm for the 2025 fiscal year.
Valuation Changes
Summary of Valuation Changes for Altria Group
- The Consensus Analyst Price Target has risen from $58.54 to $61.62.
- The Consensus Revenue Growth forecasts for Altria Group has significantly risen from 0.1% per annum to 0.4% per annum.
- The Discount Rate for Altria Group has risen slightly from 7.42% to 7.72%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.